MTERF2 antibodies are immunological reagents targeting the human mitochondrial transcription termination factor 2, a 39 kDa protein localized in the mitochondrial matrix . Two primary classes exist:
| Type | Clonality | Host | Key Applications |
|---|---|---|---|
| Monoclonal | Mouse IgG1/2a | Mouse | Immunoprecipitation, Immunoblotting |
| Polyclonal | Rabbit IgG | Rabbit | Western Blot (WB), Immunohistochemistry (IHC) |
Monoclonal antibodies (e.g., those developed by immunizing BALB/c mice with His-tagged MTERF2 ) offer high specificity, while polyclonal variants (e.g., STJ195244, HPA003526 ) provide broader epitope recognition.
MTERF2 antibodies have been instrumental in:
Protein Localization: Confirming mitochondrial matrix localization via immunofluorescence and subcellular fractionation .
Expression Analysis: Detecting serum-induced downregulation in glioma cells (e.g., 60% reduction in U251 cells after serum exposure ).
OXPHOS Studies: Identifying OXPHOS defects in MTERF2 knockout mice, including:
Mitochondrial Proliferation: Quantifying citrate synthase activity increases (up to 4.5-fold in ketogenic diet-fed mice ).
Sensitivity: Detected recombinant MTERF2 at 1:1,000 dilution in immunoblotting .
Specificity: No cross-reactivity with other MTERF family members (e.g., MTERF1, MTERF3) .
| Product | Host | Dilution Range | Applications |
|---|---|---|---|
| STJ195244 | Rabbit | 1:500–1:2,000 | WB, IHC |
| HPA003526 | Rabbit | 0.04–0.4 µg/ml | WB, IHC (HIER pH6) |
Both antibodies show reactivity across human, mouse, and rat samples .
Transcriptional Regulation: MTERF2 binds mtDNA promoter regions and interacts with mTERF3 to fine-tune transcription .
Metabolic Stress Response: In ketogenic diet-fed MTERF2 knockout mice:
Therapeutic Insights: MTERF2 depletion upregulates mTERF3 (5-fold) and TFB2 (3-fold), suggesting compensatory mechanisms .